NovaBay Pharmaceuticals, Inc. (NBY): Price and Financial Metrics
Today's Latest Price: $0.61 USD
Oct 30 8:00pm Add NBY to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
NBY Stock Summary The capital turnover (annual revenue relative to shareholder's equity) for NBY is 9.35 -- better than 96.57% of US stocks. Equity multiplier, or assets relative to shareholders' equity, comes in at 10.72 for NovaBay Pharmaceuticals Inc; that's greater than it is for 94.09% of US stocks. With a year-over-year growth in debt of -69.39%, NovaBay Pharmaceuticals Inc's debt growth rate surpasses merely 3.38% of about US stocks. If you're looking for stocks that are quantitatively similar to NovaBay Pharmaceuticals Inc, a group of peers worth examining would be HBB, WTER, APAM, KIRK, and SYPR. NBY's SEC filings can be seen here. And to visit NovaBay Pharmaceuticals Inc's official web site, go to www.novabay.com.
NBY Price/Volume Stats
NovaBay Pharmaceuticals, Inc. (NBY) Company Bio
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes non-antibiotic anti-infective products for the eye care market in the United States. The company was founded in 2000 and is based in Emeryville, California.
NBY Latest News Stream
All News Types
Commentary Guidance Up Mgmt Change New Coverage (Bullish) New Coverage (Neutral) Stock Offering
Loading, please wait...
Latest NBY News From Around the Web
Below are the latest news stories about NovaBay Pharmaceuticals Inc that investors may wish to consider to help them evaluate NBY as an investment opportunity.
NovaBay Pharmaceuticals (NBY) surges 36% premarket on the launch of Avenova on Walmart.com.“Avenova has always demonstrated the ability to kill a wide variety of pathogens, and we now have laboratory results proving it as a COVID-killer on hard surfaces,” said Justin Hall, CEO.Avenova is used for eyelid and eyelash cleansing and removal of foreign...
NovaBay Pharmaceuticals, Inc. (NBY) Q2 2020 Earnings Conference Call August 6, 2020 16:30 ET Company Participants Yvonne Briggs - Vice President, LHA Justin Hall - President & Chief Executive Officer Andrew Jones - Chief Financial Officer & Treasurer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Presentation Operator Welcome to...
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay reports second quarter 2020 financial results.
NovaBay Pharmaceuticals to Hold Second Quarter 2020 Conference Call on August 6
NovaBay Pharmaceuticals Announces Laboratory Results Confirm Avenova Kills SARS-CoV-2
Read More 'NBY' Stories Here
NBY Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.8292 seconds.